Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days

Data in Brief

Volumn 10, Issue , 2017, Pages 283-293

  Haziza, Christelle ^a   de La Bourdonnaye, Guillaume ^a   Skiada, Dimitra ^a   Ancerewicz, Jacek ^a   Baker, Gizelle ^a   Picavet, Patrick ^a   Lüdicke, Frank ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Clinical study; Reduced risk product; Tobacco exposure; Tobacco heating system 2.2

Indexed keywords

BIOMARKERS; HEATING; HEATING EQUIPMENT; SMOKE;

% REDUCTIONS; CIGARETTE SMOKES; CLINICAL STUDY; DATA SET; DESCRIPTIVE STATISTICS; EXPOSURE LEVEL; HEATING SYSTEM; REDUCED-RISK PRODUCTS; TOBACCO EXPOSURE; TOBACCO HEATING SYSTEM 2.2;

TOBACCO;

EID: 85017314037     PISSN: None     EISSN: 23523409     Source Type: Journal    
DOI: 10.1016/j.dib.2016.11.047     Document Type: DP

References (2)

1. [1] Haziza, C., de La Bourdonnaye, G., Skiada, D., Ancerewicz, J., Baker, G., Picavet, P., Lüdicke, F., Evaluation of the reduction in biomarker of exposure levels in smokers switching from conventional cigarettes to tobacco heating system 2.2 relative to smokers continuing smoking and smokers abstaining from smoking. Regul. Toxicol. Pharmacol., 2016 In press.
2. [2] FDA (Food and Drug Administration), Guidance for industry. Analytical Procedures and Methods Validation for Drugs and Biologics, 2001.